Baricitinib
Chemical compound
Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2.
Nº Q4860707 ★
Common · Knowledge
Baricitinib
Chemical compound
Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia areata, and COVID-19. It acts as an inhibitor of janus kinase (JAK), blocking the subtypes JAK1 and JAK2. Baricitinib is approved for medical use in the European Union and in the United States.
Text: Wikipédia, CC BY-SA 4.0. · Image: Vaccinationist (Public domain) ·
Related cards
-
Sunitinib
Chemical compound
Nº Q417542 ★
Not listed
-
Adalimumab
Pharmaceutical drug
Nº Q348260 ★★★
Not listed
-
Secukinumab
Monoclonal antibody against IL-17 used for treatment of psoriasis
Nº Q7444755 ★★
Not listed
-
Upadacitinib
Chemical compound
Nº Q27074125 ★★
Not listed
-
A
Alirocumab
Pharmaceutical drug
Nº Q4726914 ★
Not listed
-
Zanubrutinib
Chemical compound
Nº Q75192022 ★
Not listed